Purpose Six forms relating to decisions on life-sustaining treatment (LST) for patients at the end-of-life (EOL) in hospital are required by the “Act on Decision of LST for Patients at the EOL.” We investigated the preparation and creation status of these documents from the database of the National Agency for Management of LST.
Materials and Methods We analyzed the contents and details of each document necessary for decisions on LST, and the creation status of forms. We defined patients completing form 1 as “self-determined” of LST, and those whose family members had completed form 11/12 as “family decision” of LST. According to the determination subject, we compared the four items of LST on form 13 (the paper of implementation of LST) and the documentation time interval between forms.
Results The six forms require information about the patient, doctor, specialized doctor, family members, institution, decision for LST, and intention to use hospice services. Of 44,381 who had completed at least one document, 36,693 patients had form 13. Among them, 11,531, 10,976, and 12,551 people completed forms 1, 11, and 12, respectively. The documentation time interval from forms 1, 11, or 12 to form 13 was 8.6±13.6 days, 1.0±9.5 days, and 1.5±9.7 days, respectively.
Conclusion The self-determination rate of LST was 31% and the mean time interval from self-determination to implementation of LST was 8.6 days. The creation of these forms still takes place when the patients are close to death.
Citations
Citations to this article as recorded by
Healthcare utilization and end-of-life care based on life-sustaining treatment decisions in patients with cancer Soyou Park, Soo-Young Yu Supportive Care in Cancer.2026;[Epub] CrossRef
Shared decision-making with family involvement in Korean healthcare: a narrative review Sang-Ho Yoo Journal of the Korean Medical Association.2026; 69(7): 577. CrossRef
Orden de no reanimar en pacientes oncológicos en la UCI Gustavo Batista Ferro, Carlos Arthur da Silva Morais, Erick Antonio Rodrigues Mendes, Francinei Gomes Pinto, Marcelo Gaia Epifane, Ana Cristina Vidigal Soeiro Revista Bioética.2025;[Epub] CrossRef
Do-not-resuscitate order in ICU cancer patients Gustavo Batista Ferro, Carlos Arthur da Silva Morais, Erick Antonio Rodrigues Mendes, Francinei Gomes Pinto, Marcelo Gaia Epifane, Ana Cristina Vidigal Soeiro Revista Bioética.2025;[Epub] CrossRef
Ordem de não reanimação em pacientes oncológicos na UTI Gustavo Batista Ferro, Carlos Arthur da Silva Morais, Erick Antonio Rodrigues Mendes, Francinei Gomes Pinto, Marcelo Gaia Epifane, Ana Cristina Vidigal Soeiro Revista Bioética.2025;[Epub] CrossRef
Advance Care Planning in South Korea Yu Jung Kim, Sun-Hyun Kim Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68. CrossRef
Use of antimicrobial agents in actively dying inpatients after suspension of life-sustaining treatments: Suggestion for antimicrobial stewardship Dayeong Kim, Subin Kim, Kyoung Hwa Lee, Sang Hoon Han Journal of Microbiology, Immunology and Infection.2022; 55(4): 651. CrossRef
The Law Changes Behaviors: Is It Just Enough? Dae Ho Lee Cancer Research and Treatment.2021; 53(4): 895. CrossRef
Purpose This study aimed to investigate difficulties doctors experience during life-sustaining treatment (LST) discussion with seriously ill patients and their families after enactment of the LST Decisions Act in February 2018.
Materials and Methods A cross-sectional survey was conducted in a tertiary hospital in the Republic of Korea in August 2019. Six hundred eighty-six doctors who care for seriously ill patients were given a structured questionnaire, and difficulties during the discussion were examined.
Results One hundred thirty-two doctors completed the questionnaire. Eighty-five percent answered they treat cancer patients. Most (86.4%) experienced considerable difficulties during LST discussions (mean score, 7.4±1.6/10). The two most common difficulties were communication with patients and family and determining when to discuss LST. Two-thirds of doctors found direct discussions with the patient difficult and said they would initiate LST discussions only with family. LST discussions were actually initiated later than considered appropriate. When medically assessing whether the patient is imminently dying, 56% of doctors experienced disagreements with other doctors, which could affect their decisions.
Conclusion This study found that most doctors experienced serious difficulties regarding communication with patients and family and medical assessment of dying process during LST discussions. To alleviate these difficulties, further institutional support is needed to improve the LST discussion between doctors, patients, and family.
Citations
Citations to this article as recorded by
Awareness, attitudes, and educational needs regarding the life-sustaining treatment decision-making act in Korea among healthcare providers and medical students: a comparative analysis Jooseon Lee, So-yun Kim, Duk-ki Kim, Green Hong, Song I Lee BMC Medical Ethics.2026;[Epub] CrossRef
Rédaction d’un modèle de directives anticipées approprié pour les femmes atteintes d’un cancer du sein : méthode Delphi Bernard Frèche, Axelle Martinet, Yaritza Carneiro, Marc Besnier, Élodie Poupin Santé Publique.2026; vol. 38(2): 203. CrossRef
Shared decision-making with family involvement in Korean healthcare: a narrative review Sang-Ho Yoo Journal of the Korean Medical Association.2026; 69(7): 577. CrossRef
Nurses' engagement in advance care planning practices: A descriptive cross‐sectional study Sangmin Lee, Naixue Cui, Hyejin Kim Journal of Clinical Nursing.2025; 34(6): 2149. CrossRef
Patterns of engagement in advance care planning among older people living with cancer: a cross-sectional survey Supakorn Sripaew, Jennifer Philip, Anna Collins, Pawita Limsomwong, Jennifer Weil, Rungarun Kittichest, Polathep Vichitkunakorn, Sawitri Assanangkornchai BMC Palliative Care.2025;[Epub] CrossRef
Navigating shared decision-making after the Life-Sustaining Treatment Decision Act: a qualitative study of in-depth interviews with terminal cancer patients, families, and healthcare professionals Soo-Young Yu, Yu-eun Lee, Sung Joon Shin, Go-un Woo, Dalyong Kim, Jung Hye Kwon, Do Yeun Kim, Eunyoung Eunice Suh Supportive Care in Cancer.2024;[Epub] CrossRef
Advance Care Planning in Palliative Care in Asia: Barriers and Implications Yoo Jeong Lee, Sun-Hyun Kim, Shin Hye Yoo, A-Sol Kim, Cheng-Pei Lin, Diah Martina, Masanori Mori, Sang-Yeon Suh Journal of Hospice and Palliative Care.2024; 27(4): 107. CrossRef
Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life Jung Sun Kim, Jeongmi Shin, Nam Hee Kim, Sun Young Lee, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo Cancer Medicine.2023; 12(13): 14612. CrossRef
Ethical Issues Referred to Clinical Ethics Support at a University Hospital in Korea: Three-Year Experience After Enforcement of Life-Sustaining Treatment Decisions Act Shin Hye Yoo, Yejin Kim, Wonho Choi, Jeongmi Shin, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Jae-Joon Yim Journal of Korean Medical Science.2023;[Epub] CrossRef
Advance Care Planning in South Korea Yu Jung Kim, Sun-Hyun Kim Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68. CrossRef
Physicians’ attitudes and experiences about withholding/withdrawing life-sustaining treatments in pediatrics: a systematic review of quantitative evidence Yajing Zhong, Alice Cavolo, Veerle Labarque, Chris Gastmans BMC Palliative Care.2023;[Epub] CrossRef
Public awareness of advance care planning and hospice palliative care: a nationwide cross-sectional study in Korea Boram Kim, Junyong Lee, Youn Seon Choi BMC Palliative Care.2023;[Epub] CrossRef
Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim Cancer Research and Treatment.2022; 54(1): 20. CrossRef
Physician decision-making process about withholding/withdrawing life-sustaining treatments in paediatric patients: a systematic review of qualitative evidence Yajing Zhong, Alice Cavolo, Veerle Labarque, Chris Gastmans BMC Palliative Care.2022;[Epub] CrossRef
Association of perceived life satisfaction with attitudes toward life-sustaining treatment among the elderly in South Korea: a cross-sectional study Il Yun, Hyunkyu Kim, Eun-Cheol Park, Suk-Yong Jang BMC Palliative Care.2022;[Epub] CrossRef
Awareness of Doctors’ Shared Decision-Making in Life-Sustaining Care Decisions Dalyong Kim, Hyun Jung Lee, Soo-Young Yu, Jung Hye Kwon, Hee Kyung Ahn, Jee Hyun Kim, Seyoung Seo, Chi Hoon Maeng, Seungtaek Lim, Do Yeun Kim, Sung Joon Shin The Korean Journal of Hospice and Palliative Care.2021; 24(4): 204. CrossRef
PURPOSE It is important to balance the appropriateness of active cancer treatments and end-of-life care to improve the quality of life for terminally ill cancer patients. This study describes the treatment patterns and end-of-life care in terminal gastric cancer patients. MATERIALS AND METHODS We retrospectively analyzed the records of 137 patients with advanced gastric cancer receiving chemotherapy and dying between June 1, 2006 and May 31, 2011. We recorded interval between last chemotherapy dose and death; frequency of emergency room visits or admission to the intensive care unit in the last month before death; rate of hospice referral and agreement with written do-not-resuscitate orders; and change in laboratory values in the last three months before death. RESULTS During the last six months of life, 130 patients (94.9%) received palliative chemotherapy; 86 (62.7%) during the final two months; 41 (29.9%) during the final month.
During the final month, 53 patients (38.7%) visited an emergency room more than once; 21 (15.3%) were admitted to the intensive care unit. Hospice referral occurred in 54% (74 patients) of the patients; 93.4% (128 patients) gave written do-not-resuscitate orders. Platelets, aspartate aminotransferase and creatinine changed significantly two weeks before death; total bilirubin, one month before; and C-reactive protein, between four and two weeks before death. CONCLUSION Our results demonstrated that a significant proportion of gastric cancer patients received palliative chemotherapy to the end of life and the patients who stopped the chemotherapy at least one month before death had a lower rate of intensive care unit admission and longer overall survival than those who sustained aggressive chemotherapy until the last months of their lives.
Citations
Citations to this article as recorded by
Latent transition analysis of end-of-life care trajectories among cancer patients in South Korea: a nationwide cohort study Goun Park, Wankyo Chung BMC Health Services Research.2026;[Epub] CrossRef
Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018 Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi BMC Palliative Care.2024;[Epub] CrossRef
Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer Gopika SenthilKumar, Sharadhi Madhusudhana, Madelyn Flitcroft, Salma Sheriff, Samih Thalji, Jennifer Merrill, Callisia N. Clarke, Ugwuji N. Maduekwe, Susan Tsai, Kathleen K. Christians, T. Clark Gamblin, Anai N. Kothari Scientific Reports.2023;[Epub] CrossRef
A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer Chetna Malhotra, Filipinas Bundoc, Isha Chaudhry, Irene Teo, Semra Ozdemir, Eric Finkelstein, Rebecca A. Dent, Nesaretnam Barr Kumarakulasinghe, Yin Bun Cheung, Rahul Malhotra, Ravindran Kanesvaran, Alethea Chung Pheng Yee, Noreen Chan, Huei Yaw Wu, Soh M BMC Palliative Care.2022;[Epub] CrossRef
Quality of End-of-Life Care in Gastrointestinal Cancers: A 13-Year Population-Based Retrospective Analysis in Ontario, Canada Caitlin SR Lees, Hsien Seow, Kelvin KW Chan, Anastasia Gayowsky, Aynharan Sinnarajah Current Oncology.2022; 29(12): 9163. CrossRef
Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study Joost Besseling, Jan Reitsma, Judith A. Van Erkelens, Maike H. J. Schepens, Michiel P. C. Siroen, Cathelijne M. P. Ziedses des Plantes, Mark I. van Berge Henegouwen, Laurens V. Beerepoot, Theo Van Voorthuizen, Lia Van Zuylen, Rob H. A. Verhoeven, Hanneke Cancers.2021; 13(1): 145. CrossRef
Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews M. Santero, J. Pérez-Bracchiglione, R. Acosta-Dighero, A. G. Meade, A. Antequera, A. Auladell-Rispau, M. J. Quintana, C. Requeijo, G. Rodríguez-Grijalva, K. Salas-Gama, R. Dorantes-Romandia, J. Salazar, I. Solà, G. Urrútia, X. Bonfill Cosp BMC Cancer.2021;[Epub] CrossRef
Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts Helena Ullgren, Per Fransson, Anna Olofsson, Ralf Segersvärd, Lena Sharp, Amir Radfar PLOS ONE.2021; 16(7): e0254673. CrossRef
Health care utilization among patients with oesophageal and gastric cancer: the impact of initial treatment strategy and assignment of a contact nurse Karin Dalhammar, Marlene Malmström, Magnus Sandberg, Dan Falkenback, Jimmie Kristensson BMC Health Services Research.2021;[Epub] CrossRef
Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review Paul R. Duberstein, Michael Chen, Michael Hoerger, Ronald M. Epstein, Laura M. Perry, Sule Yilmaz, Fahad Saeed, Supriya G. Mohile, Sally A. Norton Journal of Pain and Symptom Management.2020; 59(4): 894. CrossRef
The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study Karin Dalhammar, Marlene Malmström, Maria Schelin, Dan Falkenback, Jimmie Kristensson, Jason Chia-Hsun Hsieh PLOS ONE.2020; 15(6): e0235045. CrossRef
Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer Si Won Lee, Hyun Jung Jho, Ji Yeon Baek, Eun Kyung Shim, Hyun Mi Kim, Ji Yeon Ku, Eun Jung Nam, Yoon-Jung Chang, Hye Jin Choi, Sun Young Kim American Journal of Hospice and Palliative Medicine®.2018; 35(1): 166. CrossRef
Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012 Adan Z. Becerra, Christian P. Probst, Fergal J. Fleming, Zhaomin Xu, Christopher T. Aquina, Carla F. Justiniano, Courtney I. Boodry, Alex A. Swanger, Katia Noyes, Alan W. Katz, John R. Monson, Todd A. Jusko American Journal of Hospice and Palliative Medicine®.2018; 35(2): 336. CrossRef
Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective Delong Liu, Dhruv Mehta, Supreet Kaur, Arun Kumar, Kaushal Parikh, Lavneet Chawla, Shanti Patel, Amirta Devi, Aparna Saha Journal of Hematology & Oncology.2018;[Epub] CrossRef
Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma Eli L. Diamond, Katherine S. Panageas, Alexis Dallara, Ariel Pollock, Allison J. Applebaum, Alan C. Carver, Elena Pentsova, Lisa M. DeAngelis, Holly G. Prigerson Journal of Pain and Symptom Management.2017; 53(2): 257. CrossRef
The effects of hospice-shared care for gastric cancer patients Kun-Siang Huang, Shih-Ho Wang, Seng-Kee Chuah, Kun-Ming Rau, Yu-Hung Lin, Meng-Che Hsieh, Li-Hsueh Shih, Yen-Hao Chen, Ramon Andrade de Mello PLOS ONE.2017; 12(2): e0171365. CrossRef
Clinical significance and predicting indicators of post‐cancer‐treatment survival in terminally ill patients with ovarian cancer Fumi Utsumi, Hiroaki Kajiyama, Kaoru Niimi, Ryuichiro Sekiya, Jun Sakata, Shiro Suzuki, Kiyosumi Shibata, Mika Mizuno, Fumitaka Kikkawa Journal of Obstetrics and Gynaecology Research.2017; 43(2): 365. CrossRef
Adopting Advance Directives Reinforces Patient Participation in End-of-Life Care Discussion Ji Hyung Hong, Jung Hye Kwon, Il Kyu Kim, Jin Hee Ko, Yi-Jin Kang, Hoon-Kyo Kim Cancer Research and Treatment.2016; 48(2): 753. CrossRef
Cases and Literature Review of Timing for Withdrawal of Palliative Chemotherapy Yun Jin Jeong, Do Yeun Kim The Korean Journal of Hospice and Palliative Care.2016; 19(1): 70. CrossRef
End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study I. Gallais Sérézal, Y. Beaussant, P. Rochigneux, C. Tournigand, R. Aubry, B. Lindelöf, L. Morin British Journal of Dermatology.2016; 175(3): 583. CrossRef
Trends in the Aggressiveness of End-of-Life Cancer Care in the State of Qatar Azza A. Hassan, Hassan Mohsen, Ayman A. Allam, Pascale Haddad Journal of Global Oncology.2016; 2(2): 68. CrossRef
Investigational tests and treatments performed in terminal stage cancer patients in two weeks before death: Turkish oncology group (TOG) study İbrahim Türker, Şeref Kömürcü, Ali Arıcan, Hatice Doruk, Özgür Özyılkan, Hasan Şenol Coşkun, Dilşen Çolak, Emel Üçgül Çavuşoğlu, Alper Ata, Ahmet Sezer, Havva Yeşil Çınkır, Filiz Çay Şenler, Fikret Arpacı Medical Oncology.2014;[Epub] CrossRef